07.06.2020

Sanofi, GlaxoSmithKline near $625M COVID-19 vaccine supply deal with U.K. government: report

Sanofi, GlaxoSmithKline near $625M COVID-19 vaccine supply deal with U.K. government: report aliu Mon, 07/06/2020 - 09:04
07.03.2020

Pharma's pandemic response could help attract tech talent, Novartis digital chief says

Pharma's pandemic response could help attract tech talent, Novartis digital chief says beth.bulik Fri, 07/03/2020 - 15:42
07.02.2020

FiercePharmaPolitics—Grassley's bipartisan drug pricing push in limbo as lawmakers stop negotiating

FiercePharmaPolitics—Grassley's bipartisan drug pricing push in limbo as lawmakers stop negotiating esagonowsky Thu, 07/02/2020 - 12:07
07.02.2020

With new settlement, Novartis has shelled out $1.3B for kickbacks, bribery and price fixing this year

With new settlement, Novartis has shelled out $1.3B for kickbacks, bribery and price fixing this year aliu Thu, 07/02/2020 - 11:19
07.02.2020

Pfizer, Novartis and more halt July ads on Facebook to protest hate and racism

Pfizer, Novartis and more halt July ads on Facebook to protest hate and racism beth.bulik Thu, 07/02/2020 - 11:18
07.02.2020

Tesla teams up with CureVac to make 'RNA microfactories' for COVID-19 shot, Musk says

Tesla teams up with CureVac to make 'RNA microfactories' for COVID-19 shot, Musk says kblankenship Thu, 07/02/2020 - 10:53
07.02.2020

'They're more hated than COVID-19': Minnesota governor blasts PhRMA for insulin pricing lawsuit

'They're more hated than COVID-19': Minnesota governor blasts PhRMA for insulin pricing lawsuit esagonowsky Thu, 07/02/2020 - 10:53
07.02.2020

J&J scores Ebola vaccine approval in Europe. Can the platform win again in COVID-19?

J&J scores Ebola vaccine approval in Europe. Can the platform win again in COVID-19? esagonowsky Thu, 07/02/2020 - 09:37
07.02.2020

Amgen's Enbrel fends off biosimilar threat—and heads toward blockbuster superstardom

Amgen's Enbrel fends off biosimilar threat—and heads toward blockbuster superstardom arlene.weintraub Thu, 07/02/2020 - 09:33
07.02.2020

FiercePharmaAsia—GSK's, Akebia's anemia nods; Takeda's Xiidra loss and $900M gene therapy deal

FiercePharmaAsia—GSK's, Akebia's anemia nods; Takeda's Xiidra loss and $900M gene therapy deal aliu Thu, 07/02/2020 - 09:30